Hadlima on SilverScript Choice (S5601-054)
adalimumab-bwwd
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 22.4 per 365 days.
$638.38
Patient pays / month, after deductible
$1,099.63
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
HADLIMA 40 mg/.4mL Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,553.50 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| HADLIMA 40 mg/.8mL Solution | 5 | $676.76 | PA · 44.8 per 365 days |
| HADLIMA 40 mg/.8mL Solution | 5 | $676.76 | PA · 44.8 per 365 days |
| HADLIMA 40 mg/.4mL Solution | 5 | $646.16 | PA · 22.4 per 365 days |
| HADLIMA 40 mg/.4mL Solution | 5 | $638.38 | PA · 22.4 per 365 days |
Other TNF blockers on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-054